Adiponectin: A versatile player of innate immunity

Journal of Molecular Cell Biology

Volumn 8, Issue 2, 2016, Pages 120-128

  Luo, Yan ^a,b   Liu, Meilian ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

adiponectin; innate immunity; innate like lymphocyte; macrophage

Indexed keywords

ADIPONECTIN;

CELL PLASTICITY; CELL POLARITY; CELL PROLIFERATION; DENDRITIC CELL; EOSINOPHIL; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; MACROPHAGE; METABOLIC STRESS; MONOCYTE; NATURAL KILLER T CELL; NONHUMAN; REVIEW; ANIMAL; CYTOLOGY; LYMPHOCYTE; METABOLISM; NEUTROPHIL;

ADIPONECTIN; ANIMALS; CELL POLARITY; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; MACROPHAGES; NEUTROPHILS;

EID: 84965067272     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjw012     Document Type: Review

References (106)

1. Ahima, R.S. (2006). Adipose tissue as an endocrine organ. Obesity (Silver Spring) 14(Suppl 5), 242S-249S.
2. Ajuwon, K.M., and Spurlock, M.E. (2005). Adiponectin inhibits LPS-induced NF-kB activation and IL-6 production and increases PPARg2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R1220-R1225.
3. Akbari, O., Stock, P., Meyer, E., et al. (2003). Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9, 582-588.
4. Awazawa, M., Ueki, K., Inabe, K., et al. (2011). Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab. 13, 401-412.
5. Bai, Y., and Sun, Q. (2015). Macrophage recruitment in obese adipose tissue. Obes. Rev. 16, 127-136.
6. Berg, A.H., Combs, T.P., Du, X., et al. (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947-953.
7. Bohlson, S.S., O'Conner, S.D., Hulsebus, H.J., et al. (2014). Complement, c1q, and c1q-relatedmolecules regulatemacrophagepolarization. Front. Immunol.5, 402.
8. Bourlier, V., and Bouloumie, A. (2009). Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab. 35, 251-260.
9. Brestoff, J.R., Kim, B.S., Saenz, S.A., et al. (2015). Group 2 innate lymphoid cells promote beigingof white adipose tissue and limit obesity.Nature 519, 242-246.
10. Cayrol, C., and Girard, J.P. (2014). IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr. Opin. Immunol. 31, 31-37.
11. Chawla, A., Nguyen, K.D., and Goh, Y.P. (2011). Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 11, 738-749.
12. Chedid, P., Hurtado-Nedelec, M., Marion-Gaber, B., et al. (2012). Adiponectin and its globular fragment differentially modulate the oxidative burst of primary human phagocytes. Am. J. Pathol. 180, 682-692.
13. Chen, Y., Tian, J., Tian, X., et al. (2014). Adipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells. PLoS One 9, e92450.
14. Chimen, M., McGettrick, H.M., Apta, B., et al. (2015). Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory disease. Nat. Med. 21, 467-475.
15. Chinetti, G., Zawadski, C., Fruchart, J.C., et al. (2004). Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARa, PPARg, and LXR. Biochem. Biophys. Res. Commun. 314, 151-158.
16. Costanzo, A.E., Taylor, K.R., Dutt, S., et al. (2015). Obesity impairs gd T cell homeostasis and antiviral function in humans. PLoS One 10, e0120918.
17. Denzel, M.S., Scimia, M.C., Zumstein, P.M., et al. (2010). T-cadherin is critical for adiponectin-mediated cardioprotectioninmice. J.Clin. Invest. 120, 4342-4352.
18. Duffaut, C., Galitzky, J., Lafontan, M., et al. (2009). Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem. Biophys. Res. Commun. 384, 482-485.
19. Esmaili, S., Xu, A., and George, J. (2014). The multifaceted and controversial immunometabolic actions of adiponectin. Trends Endocrinol. Metab. 25, 444-451.
20. Fisher, F.M., Trujillo, M.E., Hanif, W., et al. (2005). Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 48, 1084-1087.
21. Galvan, M.D., Hulsebus, H., Heitker, T., et al. (2014). Complement protein C1q and adiponectin stimulate Mer tyrosine kinase-dependent engulfment of apoptotic cells through a shared pathway. J. Innate Immun. 6, 780-792.
22. Gil-Campos, M., Canete, R.R., and Gil, A. (2004). Adiponectin, the missing link in insulin resistance and obesity. Clin. Nutr. 23, 963-974.
23. Girardi, M. (2006). Immunosurveillance and immunoregulation by gd T cells. J. Invest. Dermatol. 126, 25-31.
24. Goldstein, B.J., and Scalia, R. (2004). Adiponectin: A novel adipokine linking adipocytes and vascular function. J. Clin. Endocrinol. Metab. 89, 2563-2568.
25. Gordon, S., and Taylor, P.R. (2005). Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
26. Haluzik, M., Parizkova, J., and Haluzik, M.M. (2004). Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol. Res. 53, 123-129.
27. Hoffstedt, J., Arvidsson, E., Sjolin, E., et al. (2004). Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J. Clin. Endocrinol. Metab. 89, 1391-1396.
28. Holland, W.L., Miller, R.A., Wang, Z.V., et al. (2011). Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat. Med. 17, 55-63.
29. Hu, E., Liang, P., and Spiegelman, B.M. (1996). AdipoQ is a novel adiposespecific gene dysregulated in obesity. J. Biol. Chem. 271, 10697-10703.
30. Hui, X., Gu, P., Zhang, J., et al. (2015). Adiponectin enhances cold-induced browning of subcutaneous adipose tissue via promotingM2 macrophage proliferation. Cell Metab. 22, 279-290.
31. 2+ and AMPK/SIRT1. Nature 464, 1313-1319.
32. Jung, M.Y., Kim, H.S., Hong, H.J., et al. (2012). Adiponectin induces dendritic cell activation via PLCg/JNK/NF-kB pathways, leading to Th1 and Th17 polarization. J. Immunol. 188, 2592-2601.
33. Kadowaki, T., and Yamauchi, T. (2005). Adiponectin and adiponectin receptors. Endocr. Rev. 26, 439-451.
34. Kadowaki, T., Yamauchi, T., Kubota, N., et al. (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116, 1784-1792.
35. Kajimura, D., Lee, H.W., Riley, K.J., et al. (2013). Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab. 17, 901-915.
36. Kang, K., Reilly, S.M., Karabacak, V., et al. (2008). Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 7, 485-495.
37. Kim, K.Y., Kim, J.K., Han, S.H., et al. (2006). Adiponectin is a negative regulator of NK cell cytotoxicity. J. Immunol. 176, 5958-5964.
38. Kintscher, U., Hartge, M., Hess, K., et al. (2008). T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler. Thromb. Vasc. Biol. 28, 1304-1310.
39. Kouser, L., Madhukaran, S.P., Shastri, A., et al. (2015). Emerging and novel functions of complement protein C1q. Front. Immunol. 6, 317.
40. Koyasu, S., and Moro, K. (2013). Th2-type innateimmuneresponses mediatedby natural helper cells. Ann. NY Acad. Sci. 1283, 43-49.
41. Kubota, N., Yano, W., Kubota, T., et al. (2007). Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 6, 55-68.
42. Lackey, D.E., and Olefsky, J.M. (2016). Regulation of metabolism by the innate immune system. Nat. Rev. Endocrinol. 12, 15-28.
43. Lappas, M., Permezel, M., and Rice, G.E. (2005). Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kB, peroxisomal proliferator-activated receptor-g and extracellularly regulated kinase 1/2. Endocrinology 146, 3334-3342.
44. Lee, M.W., Odegaard, J.I., Mukundan, L., et al. (2015). Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160, 74-87.
45. Licona-Limon, P., Kim, L.K., Palm, N.W., et al. (2013). TH2, allergy and group 2 innate lymphoid cells. Nat. Immunol. 14, 536-542.
46. Luo, N., Liu, J., Chung, B.H., et al. (2010). Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes 59, 791-799.
47. Luo, N., Wang, X., Chung, B.H., et al. (2011). Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo. Am. J. Physiol. Endocrinol. Metab. 301, E180-E186.
48. Lynch, L., O'Shea, D., Winter, D.C., et al. (2009). Invariant NKT cells and CD1d+ cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol. 39, 1893-1901.
49. Lynch, L., Nowak, M., Varghese, B., et al. (2012). Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37, 574-587.
50. Maeda, K., Okubo, K., Shimomura, I., et al. (1996). cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem. Biophys. Res. Commun. 221, 286-289.
51. Maeda, N., Shimomura, I., Kishida, K., et al. (2002). Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8, 731-737.
52. Mandal, P., Park, P.H., McMullen, M.R., et al. (2010a). The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells. Hepatology 51, 1420-1429.
53. Mandal, P., Roychowdhury, S., Park, P.H., et al. (2010b). Adiponectin and heme oxygenase-1 suppress TLR4/MyD88-independent signaling in rat Kupffer cells and in mice after chronic ethanol exposure. J. Immunol. 185, 4928-4937.
54. Mandal, P., Pratt, B.T., Barnes, M., et al. (2011). Molecular mechanism for adiponectin-dependentM2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J. Biol. Chem. 286, 13460-13469.
55. Mantovani, A., Sica, A., Sozzani, S., et al. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
56. Mantovani, A., Biswas, S.K., Galdiero, M.R., et al. (2013). Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 229, 176-185.
57. Medoff, B.D., Okamoto, Y., Leyton, P., et al. (2009). Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am. J. Respir. Cell Mol. Biol. 41, 397-406.
58. Mehta, P., Nuotio-Antar, A.M., and Smith, C.W. (2015). gd T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J. Leukoc. Biol. 97, 121-134.
59. Molofsky, A.B., Nussbaum, J.C., Liang, H.E., et al. (2013). Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210, 535-549.
60. Nguyen, K.D., Qiu, Y., Cui, X., et al. (2011). Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480, 104-108.
61. Odegaard, J.I., and Chawla, A. (2011). Alternative macrophage activation and metabolism. Annu. Rev. Pathol. 6, 275-297.
62. Ohashi, K., Parker, J.L., Ouchi, N., et al. (2010). Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J. Biol. Chem. 285, 6153-6160.
63. Ouchi, N., Kihara, S., Arita, Y., et al. (2001). Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103, 1057-1063.
64. Ouchi, N., Kihara, S., Funahashi, T., et al. (2003). Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol. 14, 561-566.
65. Ouchi, N., Kobayashi, H., Kihara, S., et al. (2004). Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem. 279, 1304-1309.
66. Pajvani, U.B., Hawkins, M., Combs, T.P., et al. (2004). Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedionemediated improvement in insulin sensitivity. J. Biol. Chem. 279, 12152-12162.
67. Park, P.H., McMullen, M.R., Huang, H., et al. (2007). Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-a (TNF-a) expression via ERK1/2 activation and Egr-1 expression: role of TNF-a in adiponectin-stimulated interleukin-10 production. J. Biol. Chem. 282, 21695-21703.
68. Park, P.H., Huang, H., McMullen, M.R., et al. (2008a). Activation of cyclic-AMP response element binding protein contributes to adiponectin-stimulated interleukin-10 expression in RAW 264.7 macrophages. J. Leukoc. Biol. 83, 1258-1266.
69. Park, P.H., Huang, H., McMullen, M.R., et al. (2008b). Suppression of lipopolysaccharide-stimulated tumor necrosis factor-a production by adiponectin is mediated by transcriptional and post-transcriptional mechanisms. J. Biol. Chem. 283, 26850-26858.
70. Pischon, T., Girman, C.J., Hotamisligil, G.S., et al. (2004). Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291, 1730-1737.
71. Price, A.E., Liang, H.E., Sullivan, B.M., et al. (2010). Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl Acad. Sci. USA 107, 11489-11494.
72. Qiao, L., Yoo, H., Bosco, C., et al. (2014). Adiponectin reduces thermogenesis by inhibiting brown adipose tissue activation in mice. Diabetologia 57, 1027-1036.
73. Qiu, Y., Nguyen, K.D., Odegaard, J.I., et al. (2014). Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 157, 1292-1308.
74. Rao, R.R., Long, J.Z., White, J.P., et al. (2014). Meteorin-like is ahormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 157, 1279-1291.
75. Rossi, A., and Lord, J. (2013a). Adiponectin inhibits neutrophil phagocytosis of Escherichia coli by inhibition of PKB and ERK 1/2 MAPK signalling and Mac-1 activation. PLoS One 8, e69108.
76. Rossi, A., and Lord, J.M. (2013b). Adiponectin inhibits neutrophil apoptosis via activation of AMP kinase, PKB and ERK 1/2 MAP kinase. Apoptosis 18, 1469-1480.
77. Scherer, P.E., Williams, S., Fogliano, M., et al. (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746-26749.
78. Shibata, R., Sato, K., Pimentel, D.R., et al. (2005). Adiponectin protects against myocardial ischemia-reperfusion injury throughAMPK-and COX-2-dependent mechanisms. Nat. Med. 11, 1096-1103.
79. Shibata, S., Tada, Y., Hau, C.S., et al. (2015). Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from gd-T cells. Nat. Commun. 6, 7687.
80. Stefanovic-Racic, M., Yang, X., Turner, M.S., et al. (2012). Dendritic cells promote macrophage infiltration and comprise a substantial proportion of obesity-associated increases in CD11c+ cells in adipose tissue and liver. Diabetes 61, 2330-2339.
81. Takemura, Y., Ouchi, N., Shibata, R., et al. (2007). Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J. Clin. Invest. 117, 375-386.
82. Tomas, E., Tsao, T.S., Saha, A.K., et al. (2002). Enhanced muscle fat oxidationand glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl Acad. Sci. USA 99, 16309-16313.
83. Tsang, J.Y., Li, D., Ho, D., et al. (2011). Novel immunomodulatory effects of adiponectin on dendritic cell functions. Int. Immunopharmacol. 11, 604-609.
84. Tsao, T.S., Murrey, H.E., Hug, C., et al. (2002). Oligomerization state-dependent activation of NF-kB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J. Biol. Chem. 277, 29359-29362.
85. Tsatsanis, C., Zacharioudaki, V., Androulidaki, A., et al. (2005). Adiponectin induces TNF-a and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli. Biochem. Biophys. Res. Commun. 335, 1254-1263.
86. Tsatsanis, C., Zacharioudaki, V., Androulidaki, A., et al. (2006). Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin. Ann. NY Acad. Sci. 1083, 185-195.
87. Tsuchida, A., Yamauchi, T., Takekawa, S., et al. (2005). Peroxisome proliferatoractivated receptor (PPAR)a activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARa, PPARg, and their combination. Diabetes 54, 3358-3370.
88. Weisberg, S.P., McCann, D., Desai, M., et al. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808.
89. Weisberg, S.P., Hunter, D., Huber, R., et al. (2006). CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116, 115-124.
90. Wensveen, F.M., Jelencic, V., Valentic, S., et al. (2015). NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol. 16, 376-385.
91. Wilk, S., Jenke, A., Stehr, J., et al. (2013). Adiponectin modulates NK-cell function. Eur. J. Immunol. 43, 1024-1033.
92. Wolf, A.M., Wolf, D., Rumpold, H., et al. (2004). Adiponectin induces the antiinflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem. Biophys. Res. Commun. 323, 630-635.
93. Wright, H.L., Moots, R.J., Bucknall, R.C., et al. (2010).Neutrophil functionin inflammation and inflammatory diseases. Rheumatology (Oxford) 49, 1618-1631.
94. Wu, Y., Tu, Q., Valverde, P., et al. (2014). Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice. Am. J. Physiol. Endocrinol. Metab. 306, E1418-E1430.
95. Wulster-Radcliffe, M.C., Ajuwon, K.M., Wang, J., et al. (2004). Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun. 316, 924-929.
96. Xu, A., Wang, Y., Keshaw, H., et al. (2003). The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112, 91-100.
97. Yamaguchi, N., Argueta, J.G., Masuhiro, Y., et al. (2005). Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett. 579, 6821-6826.
98. Yamaguchi, N., Kukita, T., Li, Y.J., et al. (2008). Adiponectin inhibits induction of TNF-a/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett. 582, 451-456.
99. Yamamoto, R., Ueki, S., Moritoki, Y., et al. (2013). Adiponectin attenuateshuman eosinophil adhesion and chemotaxis: implications in allergic inflammation. J. Asthma 50, 828-835.
100. Yamauchi, T., Kamon, J., Waki, H., et al. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-946.
101. Yamauchi, T., Kamon, J., Ito, Y., et al. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769.
102. Yamauchi, T., Nio, Y., Maki, T., et al. (2007). Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332-339.
103. Yamauchi, T., Iwabu, M., Okada-Iwabu, M., et al. (2014). Adiponectin receptors: a review of their structure, function and how they work. Best Pract. Res. Clin. Endocrinol. Metab. 28, 15-23.
104. Yokota, T., Oritani, K., Takahashi, I., et al. (2000). Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96, 1723-1732.
105. Zacharioudaki, V., Androulidaki, A., Arranz, A., et al. (2009). Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. J. Immunol. 182, 6444-6451.
106. 2+ /calmodulin-dependent protein kinase kinase-dependent pathways. J. Biol. Chem. 284, 22426-22435.